Best Whipple Procedure Hospitals in Europe

Europe is a major hub for complex pancreatic surgery, and the Whipple procedure (pancreaticoduodenectomy) sits at the center of that expertise. As pancreatic and periampullary cancers rise in incidence and more patients are diagnosed at earlier, operable stages, demand for safe, high-quality Whipple surgery continues to grow.^[1] At the same time, the operation remains one of the most technically demanding procedures in abdominal surgery, with meaningful differences in survival, complication rates, and recovery between high-volume specialist centers and general hospitals.^[2][3]

Over the past decade, many European countries have moved toward centralizing pancreatic operations in dedicated units.^[4] These centers bring together experienced pancreatic surgeons, advanced perioperative care, interventional endoscopy, and structured rehabilitation – all of which can significantly influence outcomes after a Whipple procedure.^[5] Yet for patients, families, and referring physicians, it can still be challenging to identify which medical centre truly specializes in this operation rather than offering it occasionally as part of a broad general surgery service.^[6]

This top 10 ranking of the best Whipple procedure hospitals in Europe is designed to guide international patients, expats, and residents planning major pancreatic surgery abroad or at home. It highlights centers where pancreatic, biliary, and periampullary procedures are core focuses. Our team selects hospitals that combine strong reputations with measurable surgical outcomes, strong pancreatic surgery programs with proven experience, and patient-centered care. We deliberately exclude facilities without a consistent track record in complex pancreatic interventions.

Ranking of the Top Pancreatic Surgery Clinics

Looking for a focused shortlist of Europe’s top hospitals for the Whipple procedure, or want to compare only the most experienced centers? The table below highlights the leading 10 Whipple units, surgeons, their surgical volumes, and their core metrics within the Airomedical system.

* The surgical volume for Whipple surgeries directly influences the rating with the higher coefficient, while a broader number of pancreatic surgeries has a more minor impact.

** The year the facility began performing Whipple surgeries, according to available documentation.

Select a hospital

How Top Whipple Centers Stand Apart

Now we highlight each hospital’s core strengths, Whipple expertise, case volumes, and patient outcomes. Patients can quickly match their situation with the European center best equipped to handle it.

Behind the Doors of the Top 5 Pancreas Centers

This Top 5 snapshot of Europe’s leading pancreas centers is your fast track to the most capable hospitals for Whipple surgery. We are comparing them side-by-side, adding more specific details about each surgical unit and its leader, so you can better understand what distinguishes the clinics.

1st: Heidelberg University Hospital

Heidelberg University Hospital is leading the ranking with its European Pancreas Center (EPC). This unit is one of the largest dedicated pancreatic surgery units worldwide, performing around 700–750 pancreatic operations per year and treating over 2,000 patients with pancreatic disease annually.^[7][8]

Whipple procedures (pancreaticoduodenectomies) form a significant part of this workload, including complex cases with vascular reconstruction and minimally invasive/robotic approaches, which are studied in dedicated outcome analyses.^[9][10] In the study, among the 5,300 pancreatic operations, the center reported an overall 90-day mortality of 3.2%, with bile leakage identified as a rare but high-risk complication.^[11][12] Such data place EPC in the low-mortality range for complex pancreatic interventions.

The unit leads or co-leads multiple pancreatic cancer trials (e.g., NEOPANC, PREVADER, PancER, PROSPER), tightly linking Whipple surgery with neoadjuvant concepts and long-term outcomes research.^[13] It is headed by Prof. Dr. med. Christoph Michalski, Medical Director of Surgery and Director of the EPC, continues the high-volume, research-driven tradition established by Prof. Markus W. Büchler.

2nd: University Hospital Rechts der Isar Munich

University Hospital Rechts der Isar Munich stands out in the ranking with its DGAV-certified Excellence Center for Pancreatic Surgery.^[14] The surgical team performs approximately 140 pancreatic operations per year, meeting high German-volume standards and functioning as a true high-volume referral centre for complex pancreatic disease.^[15]

In terms of statistical structure and data, Whipple operations account for a large share of this caseload, including challenging tumours, and involve venous reconstruction and other advanced techniques. Among 118 patients undergoing venous reconstruction during pancreatectomy (65 Whipple operations), the department reported a 30- and 90-day mortality of only 0.8%, placing its results firmly in the low-mortality range for high-risk pancreatic surgery worldwide.^[16] In everyday practice, the centre combines open, laparoscopic, and robotic approaches. The clinic reports that, after complete tumour removal and modern systemic therapy, around 30–40% of patients live longer than five years, which is notable for pancreatic cancer.^[17]

The pancreatic unit at University Hospital Rechts der Isar is highly research-active, helping shape national registry and clinical data on Whipple outcomes, such as StuDoQ.^[18] Whipple surgery here is led by Prof. Dr. med. Helmut Friess (Director of the Surgical Clinic), together with translational pancreatic surgery researcher Prof. Dr. Ihsan Ekin Demir, ensures the tight integration of high-volume surgery, complication research, and clinical trials.

3rd: Verona Integrated University Hospital

Verona Integrated University Hospital features the Pancreas Institute, one of Europe’s flagship centers for pancreatic surgery. The historical series describes more than 5,500 patients with pancreatic disease managed here and over 1,350 pancreatoduodenectomies (Whipple procedures) performed, confirming its status as an actual high-volume referral unit.^[19] More recent prospective data report approximately 300–350 major pancreatic resections per year (among which the Whipple procedure accounts for approximately 150 interventions).^[20]

A landmark analysis of 3,000 consecutive pancreatoduodenectomies here showed that, despite treating increasingly frail patients and more complex pancreatic cancers (about 60% of indications, with 40% of those receiving neoadjuvant therapy), the team maintained strong safety metrics: in-hospital mortality 2.3%, failure-to-rescue 11.7%, and a 20% rate of significant complications. Regarding the complications: postoperative pancreatic fistula, hemorrhage, and delayed gastric emptying occurred in 22.4%, 13.4%, and 12.4% of patients, respectively. The figures place Verona University Hospital firmly within the low-mortality, benchmark range for complex Whipple surgery.^[21]

The Pancreas Institute also drives methodologically strong clinical and translational research, specifically in pancreatic surgery.^[23] The data range from perioperative optimization (e.g., the multicenter BIOSTEPS antibiotic stewardship program in pancreatic resections) to disease registries and imaging/pathology studies focused on pancreatic carcinoma biology and margins.^[23]

Prof. Roberto Salvia is a full Professor of Surgery and the executive chief of the Verona Pancreas Institute. The doctor has personally performed or tutored 800+ pancreatic resections, continuing the high-volume, research-driven tradition that has made Verona one of Europe’s reference centers for Whipple procedures.^[24]

4th: University Hospital Leuven

University Hospital Leuven (UZ Leuven) is a leading European center for complex pancreatic surgery and one of Belgium’s officially recognized centers of expertise for these procedures. In 2018 alone, the abdominal surgery team performed 153 complex pancreatic operations, making UZ Leuven the only Belgian hospital to exceed 100 such cases per year and to treat almost a quarter of all patients nationwide who need complex pancreatic surgery.^[25]

Whipple procedures are a significant focus, and most are now carried out using minimally invasive keyhole techniques. Over a recent 3-year period, 213 patients underwent keyhole Whipple surgery at UZ Leuven with only two deaths, bringing the fatality risk to <1% (around eight times lower than the Belgian national average).^[25] In addition, national data show that UZ Leuven’s overall 90-day mortality after complex pancreatic surgery is more than three times lower than the Belgian average, placing the unit among the world’s benchmark centers for this operation.^[25]

The Leuven team has also helped shape the modern Whipple technique and the evidence on outcomes. An extensive study from University Hospital Leuven showed that a new reconstruction method in the Whipple procedure significantly reduced complications and has since been adopted internationally. The analysis of over 500 pancreatic resections here demonstrated that, for pancreatic adenocarcinoma, minimally invasive pancreatic surgery at this high-volume center achieved better overall and disease-free survival than open surgery (median overall survival 30.7 vs 20.3 months after matching).^[26]

The pancreatic surgery unit is led by Prof. Dr. Baki Topal, clinical head of abdominal surgery and a key figure in hepatopancreatobiliary surgical oncology research, ensuring that Whipple patients benefit from both high case volume and cutting-edge clinical studies in pancreatic cancer.^[27]

5th: Catholic Clinic Bochum

Catholic Clinic Bochum, with its St. Josef-Hospital, hosts the interdisciplinary Pancreas Center, a DGAV and DKG-certified pancreatic cancer center.^[28][29] Since its founding in 2004, the center has treated 3,000–3,800 patients with pancreatic disease and, in the first years alone, has already performed around 500 pancreatic operations, including about 432 primary and 22 redo Whipple procedures, underscoring a strong focus on pancreatic head resections.^[30][31]

Bochum Pancreas Center stands out with rates of revision surgery, wound infection, and mortality clearly below required thresholds and noticeably below the German average. The clinic is managing around 155 new pancreatic cancer cases per year, making it the largest pancreatic cancer center in that comparison.^[32]

Research from Bochum’s registry covers long-term outcomes and quality of life after pancreatic surgery, as well as disease-specific series such as a 16-year series of 133 surgically treated serous cystic pancreatic neoplasms published in Pancreatology, reinforcing its profile as a high-volume academic Whipple center.^[33][34]

The pancreas centre is led by Prof. Dr. med. Waldemar Uhl, Director of the Department of General and Visceral Surgery and internationally recognized pancreatic surgeon, whose team attracts referrals from across Germany and abroad for complex Whipple and other pancreatic interventions.^[35]

Other Excellent Choices for Pancreatic Surgery

This next tier of pancreas centers offers excellent options beyond the very top ranking. These hospitals combine strong outcomes with practical benefits such as shorter wait times, experienced pancreatic teams, and firm support. Use these profiles to navigate through high-quality, but often less popular, choices for your Whipple or other pancreatic surgery.

6th: Erasmus University Medical Center

Erasmus University Medical Center in Rotterdam is represented in this ranking by the HPB Center Rotterdam, a national center of expertise for pancreatic tumors and pancreatic neuroendocrine tumors.^[36] Here, the pancreatic team performs more than 100 pancreatic operations per year, with pancreatoduodenectomy and distal pancreatectomy forming the core of its surgical activity.^[37]

Erasmus Medical Center also leads key randomized trials such as PREOPANC and PREOPANC-2, which showed that neoadjuvant treatment improves overall survival compared with upfront surgery, while maintaining low 90-day postoperative mortality (~1.4–2.9%) after pancreatic resection.^[38][39][40]

Pancreatic surgery at Erasmus is delivered by a high-volume HPB team led by Prof. Dr. Robert Porte (Head of HPB/Transplant Surgery) and Prof. Dr. Bas Groot Koerkamp, a surgical oncologist whose research focuses on pancreatic cancer and pancreaticoduodenectomy.^[41] The surgeons are working closely with pancreatic cancer surgeon-scientist Prof. Casper H.J. van Eijck.

This combination of substantial Whipple volume, national leadership in outcomes, and trial-driven, multimodal care makes Erasmus University Hospital one of Europe’s leading centers of reference.

7th: Karolinska University Hospital

Karolinska University Hospital earns its place in this ranking with its Hepatobiliary and Pancreatic (HPB) Unit. It is the largest liver and pancreas surgery center in Sweden. The unit performs around 500–550 primary oncological HPB operations per year.^[46] It serves as a national referral hub for complex pancreatic tumors, including further-centralized care for locally advanced pancreatic cancer.

971 Whipple procedures were performed between January 2008 and June 2019 in a single-center cohort of adult patients.^[47][48] That’s roughly on the order of 80–85 Whipple procedures per year on average over that period, even though the exact per-year breakdown isn’t published in the open summaries.

In a 162-patient series of chronic pancreatitis from the same center, pancreatic resections achieved a success rate of over 99%.^[49] In more radical cases, a 145-patient total pancreatectomy series from Karolinska University Hospital reported a success rate of over 94,5%, demonstrating acceptable risk even in very high-complexity surgery at this high-volume hospital.^[50]

Clinically, pancreatic and Dr. Stefan Gilg, Head of HPB Surgery, leads HPB surgery. At the same time, Prof. Ernesto Sparrelid chairs the Department for Upper Abdominal Diseases and leads the HPB surgery research group. The specialists direct the Karolinska International HPB Surgery Fellowship, ensuring that Whipple patients are treated in a highly specialized, research-driven environment.^[51]

8th: University Hospital Zurich

University Hospital Zurich houses the Swiss HPB & Transplantation Center, Switzerland’s central reference unit for complex pancreatic surgery, including Whipple procedures. The team focuses on high-risk pancreaticoduodenectomy and extended resections, often with vascular reconstruction and selected minimally invasive/robotic approaches. The results are tracked in a prospective quality database using the Clavien–Dindo system and the Comprehensive Complication Index, both developed in Zurich.^[42][43]

In a long-term analysis of the center’s workload, in-hospital mortality was approximately 2.2%, and failure-to-rescue was about 6.9%.^[44] Zurich surgeons co-authored the seminal 633-patient pancreaticoduodenectomy series that introduced a standardized grading of complications (overall 58.5%, pancreatic fistula 9%, perioperative mortality 2%), now a benchmark for Whipple outcomes worldwide.^[45]

The pancreatic program at University Hospital Zurich is headed by Prof. Dr. Pierre-Alain Clavien (department chair), with Prof. Dr. Henrik Petrowsky, Prof. Dr. Philipp Dutkowski, and colleagues leading the pancreatic and HPB surgical service.

9th: Hospital Clínic de Barcelona

Hospital Clínic de Barcelona enters the ranking through its HBP and Transplant Surgery Unit, which are nationally recognized reference centres and full members of European liver–digestive networks.^[52] Pancreatic operations are a significant focus: in a single-centre series of 213 Whipple surgeries performed between 2014 and 2020, the team reported a success rate of 98,6%.^[53] These patients were almost all operated on for malignant disease, underlining the unit’s focus on complex oncologic Whipple surgery. The data show an overall surgical volume of approximately 35 Whipple interventions each year.

Several topic-specific studies from this centre have shaped how Whipple outcomes are monitored and improved. The group has shown that post-operative day-1 systemic inflammatory response syndrome is a robust early biomarker for high-risk fistula and has quantified the risk of incisional hernia (8.8%) and its predictors in long-term follow-up after open Whipple.^[53]

Hospital Clínic in Barcelona also coordinates or leads pan-European minimally invasive pancreatic surgery projects (robotic vs laparoscopic distal pancreatectomy, obese-patient MIDP registries).^[54][55] This fact positions it at the forefront of advanced minimally invasive pancreatic surgery.

The unit is led by a dedicated HPB and transplant team headed by Prof. Juan Carlos García-Valdecasas (Head of General and Digestive Surgery) and EBSQ-HPB-certified Dr. Fabio Ausania, clinical lead in pancreato-biliary and robotic surgery.^[52] Together, they offer high-volume Whipple expertise embedded in a multidisciplinary cancer environment.

10th: Hospital Beaujon AP-HP

Hôpital Beaujon (AP-HP, Clichy) is one of France's historic hepatopancreatobiliary referral centers, with Whipple surgery at the core of its pancreatic program. The clinic's statistical data show that in a single-center series of 352 Whipple operations (2007–2011), early biliary complications occurred in 14% of patients (biliary leak 3%, cholangitis 6%, strictures 2%). The reoperation rate was 18%, with no biliary–complication–related deaths, reflecting structured complication management in a high-volume unit. From these numbers and similar studies, we can see that the annual Whipple procedure volume is around 40-80 procedures.^[56]

The team now performs both open and advanced laparoscopic Whipple procedures, including complex venous resections and even laparoscopic IVC reconstruction, and recently showed in a matched group of 128 patients treated with neoadjuvant chemoradiotherapy that laparoscopic pancreatoduodenectomy achieved similar 3% 90-day mortality, major complication rates (6–14%), hospital stay (12–13 days), and 3-year survival compared with open surgery.^[57][58]

Pancreatic surgery here is tightly integrated with Beaujon's Pancreatology and Digestive Oncology Department and the IRPAC institute, one of the few centers worldwide devoted exclusively to pancreatic diseases.^[59] The hepatopancreatobiliary & liver transplantation service is led by Prof. Mickaël Lesurtel, with Prof. Safi Dokmak as a key specialist, and minimally invasive pancreas surgery.

Select the proper clinic

Best Countries for Whipple Surgery in Europe

If you zoom out from individual hospitals and look at the map, a few countries clearly punch above their weight for Whipple surgery. It is not just because of one famous clinic, but because of how their whole healthcare ecosystem is built.

Germany

When you look at this Top 10 list, one thing jumps out immediately: Germany is the heavyweight. Heidelberg, Rechts der Isar in Munich, and Catholic Clinic Bochum all sit in the same country, and that is not an accident. Germany has a long-established culture of visceral surgery, strong certification systems for pancreas and cancer centers, and a tendency to centralize complex operations in specialist units. For a patient, that means you are not relying on a single “famous” hospital. You have a small network of genuinely experienced centers working under similar quality rules, which makes second opinions and plan changes much easier.

Italy & Belgium

Then you have countries like Italy and Belgium, where a single flagship center does much of the heavy lifting. Verona and Leuven are classic examples of hospitals that have turned pancreatic surgery into their signature field. They concentrate large numbers of Whipple procedures, build research projects around them, and often set national standards for treating pancreatic cancer. If you like the idea of “go where the whole country sends its hardest cases,” these are the kinds of places people mean.

The Netherlands & Scandinavia

The Netherlands and Sweden stand out for another reason: systems thinking. Erasmus MC in Rotterdam and Karolinska in Stockholm are embedded in national systems that track outcomes, define who is allowed to operate, and continuously adjust based on real data. Centralization is not just a slogan; it is built into how care is organized. Patients who go to these centers benefit from more than a skilled surgeon. They step into a pathway where surgery, chemo, radiation, and follow-up work together.

Switzerland, Spain & France

Lastly, Switzerland, Spain, and France come into play, with major university hospitals that have grown into natural referral hubs. Zurich, Hospital Clínic de Barcelona, and Beaujon in Paris all combine advanced pancreatic surgery with high-end imaging, intensive care, and cancer medicine on one campus. For many international patients, this is attractive because you get top-tier surgical care and, at the same time, the comfort and infrastructure of a major European city, with good flights, hotels, and support services.

Send request

Whipple Surgery Hospitals: Ranking Methodology

To establish a reliable ranking of the best clinic in Europe for the Whipple procedure, Airomedical employs a multi-factor model that combines objective performance-related data with trusted user signals and expert reviews. Each hospital’s final position is a composite, normalized score calculated from the four core factors and additional minor metrics below. We routinely refresh, adjust, and apply safeguards to ensure data completeness and prevent gaming.

Clinics cannot pay to influence placement. Sponsored content, if any, is clearly labeled and kept separate from scoring. For complete definitions, data sources, and factor-level math, consult the corresponding Help Centre pages.

Clinics must have a verifiable identity and provide sufficient data to be ranked. We reprocess inputs on a rolling basis and re-run the model when material updates occur (e.g., new certifications, primary outcomes releases).

All factors are placed on comparable scales and weighted to determine a narrow clinic rating specifically for Whipple surgery, limited to Europe. We emphasize patient-important outcomes, safety, and validated care quality, while also reflecting access, transparency, and user experience. Ties are broken in the order of clinical outcomes, then safety, and finally, access. When data are incomplete, we use conservative estimates or omit the metric to avoid unfair bias; missing data never improve a hospital’s rank.

Core Metrics

Below is a brief overview of the core metrics that drive our rankings: AiroScore, UserScore, the Clinical Quality Dataset, and Editorial Verification. This section summarizes what each means and how it fits into the composite score; it’s intentionally high-level. Technical deep-dives for each factor are available in our Help Centre.

Integrated AiroScore

AiroScore is our unified metric that combines verified hospital profile data, such as accreditation of the clinic and its adjacent laboratories, clinician and departmental strength, transparency in offerings, service quality, profile completeness, and freshness, with aggregated user-behavior signals to create a single, comparable score. It is worth noting that UserScore (below) is one of AiroScore’s sub-components; however, AiroScore also captures broader institutional strength and service readiness. Inputs are standardized to comparable scales, weighted by demonstrated impact on outcomes and patient decision-making, then aggregated into a single score.

Patient Experience via UserScore

UserScore evaluates the credibility and substance of user feedback - not just star averages. Each review is assigned a TrustScore based on the integrity of its source, reviewer signals, and the quality of its content. We also model credibility over time (periodicity and history), reviewer diversity, case complexity, review volume and recency, and textual specificity (e.g., mentions of care coordination, nursing, discharge, digital touchpoints). The result is a robust user-experience measure that resists outliers and fake or low-information reviews.

Comprehensive Statistical Clinical Quality Dataset

This factor summarizes risk-adjusted clinical performance and operational reliability, as reported by trusted statistical sources. It spans outcomes and patient safety, experience (number of Whipple surgeries per year), access, workforce and efficiency, education and innovation, technology/data compliance, and key specialty process checks. Among the factors in pancreatic surgery are the number of studies in the field, results, the scope of scientific papers presented by a particular clinic, as well as patents and registration details for innovative methods. Metrics are normalized and, where relevant, case-mix adjusted, then rolled into a single clinical-quality subscore.

Editorial Verification

Before publication, our editorial team conducts manual checks to verify identities, resolve data discrepancies, confirm unusual values, and review borderline rank changes. Editors verify critical details (e.g., certification status, actual availability of the mentioned core methods) and approve the final list to minimize technical errors. Human oversight remains an essential safeguard.

Additional Factors

To ensure the list reflects the European Whipple surgery profile, we also review the medical team (doctors) leading the pancreatic surgery units in each hospital. Exploring surgical personalities helps add valuable metrics based on personal surgical experience, individual approaches, research, and offerings. Even more, we have added the track record for Whipple operations (how long the facility has been involved in the surgery). This additional factor helps enhance the experience beyond pure surgical volume.

Choose a clinic

FAQ

References

1. Partyka, O., Pajewska, M., Kwaśniewska, D., Czerw, A., Deptała, A., Budzik, M., Cipora, E., Gąska, I., Gazdowicz, L., Mielnik, A., Sygit, K., Sygit, M., Krzych-Fałta, E., Schneider-Matyka, D., Grochans, S., Cybulska, A. M., Drobnik, J., Bandurska, E., Ciećko, W., Ratajczak, P., Kamecka, K., Marczak, M., & Kozłowski, R. (2023, July 15). Overview of Pancreatic Cancer Epidemiology in Europe and Recommendations for Screening in High-Risk Populations. Cancers, 15(14), 3634. https://doi.org/10.3390/cancers15143634. Retrieved October 2025.
2. van der Geest, L. G. M., van Rijssen, L. B., Molenaar, I. Q., de Hingh, I. H., Groot Koerkamp, B., Busch, O. R. C., Lemmens, V. E. P. P., & Besselink, M. G. H. (2016, April). Volume–outcome relationships in pancreatoduodenectomy for cancer. HPB, 18(4), 317–324. https://doi.org/10.1016/j.hpb.2016.01.515. Retrieved October 2025.
3. Birkmeyer, J. D., Siewers, A. E., Finlayson, E. V. A., Stukel, T. A., Lucas, F. L., Batista, I., Welch, H. G., & Wennberg, D. E. (2002, April 11). Hospital volume and surgical mortality in the United States. New England Journal of Medicine, 346(15), 1128–1137. https://doi.org/10.1056/NEJMsa012337. Retrieved October 2025.
4. Polonski, A., Izbicki, J. R., & Uzunoglu, F. G. (2019, October). Centralization of pancreatic surgery in Europe. Journal of Gastrointestinal Surgery, 23(10), 2081–2092. https://doi.org/10.1007/s11605-019-04215-y. Retrieved November 2025.
5. Gooiker, G. A., van der Geest, L. G. M., Wouters, M. W. J. M., Vonk, M., Karsten, T. M., Tollenaar, R. A. E. M., & Bonsing, B. A. (2011, May 5). Quality improvement of pancreatic surgery by centralization in the western part of the Netherlands. Annals of Surgical Oncology, 18, 1821–1829. https://doi.org/10.1245/s10434-010-1511-4. Retrieved November 2025.
6. Dutch Pancreatic Cancer Group, van Rijssen, L. B., Zwart, M. J., van Dieren, S., de Rooij, T., Bonsing, B. A., … van Gulik, T. M. (2018, August). Variation in hospital mortality after pancreatoduodenectomy is related to failure to rescue rather than major complications: a nationwide audit. HPB, 20(8), 759–767. https://doi.org/10.1016/j.hpb.2018.02.640. Retrieved November 2025.
7. Heidelberg University Hospital, European Pancreas Center. (2025). The European Pancreas Center at Heidelberg University Hospital. Retrieved November 2025.
8. National Center for Tumor Diseases (NCT), Heidelberg. CP Pancreatic – Clinical Cancer Research Program. Retrieved November 2025.
9. Kinny-Koester, B. Robot surgery: Robotic pancreatic surgery. European Pancreas Center Heidelberg. Retrieved November 2025
10. Müller, P. C., Müller-Stich, B. P., Hackert, T., & Nickel, F. (2022, June 1). Robotic pancreaticoduodenectomy after the learning curve—a new hope. Hepatobiliary Surgery and Nutrition, 11(3), 489–491. https://doi.org/10.21037/hbsn-22-18. Retrieved November 2025.
11. Ho, C.-K., Kleeff, J., Friess, H., & Büchler, M. W. (2005). Complications of pancreatic surgery. HPB, 7(2), 99–108. https://doi.org/10.1080/13651820510028936. Retrieved November 2025.
12. Mehrabi, A., Abbasi Dezfouli, S., Schlösser, F., Ramouz, A., Khajeh, E., Ali-Hasan-Al-Saegh, S., Loos, M., Strobel, O., Müller-Stich, B., Berchtold, C., Mieth, M., Klauss, M., Chang, D.-H., Wielpütz, M. O., Büchler, M. W., & Hackert, T. (2022, June 24). Validation of the ISGLS classification of bile leakage after pancreatic surgery: A rare but severe complication. European Journal of Surgical Oncology, 48(12), 2440–2447. https://doi.org/10.1016/j.ejso.2022.06.030. Retrieved November 2025.
13. European Pancreas Center, Heidelberg. Clinical studies. Retrieved October 2025.
14. TUM Klinikum Rechts der Isar. (2024, March 18). Zertifikate. Retrieved November 2025.
15. Klinikum rechts der Isar, Technische Universität München. (2022). Rechts der Isar aktuell – 55 Jahre Universitätsklinikum rechts der Isar (Ausgabe 3/2022). Retrieved November 2025.
16. Dokmak, S., Aussilhou, B., Chérif, R., Barbier, L., Cauchy, F., & colleagues. (2019). Venous reconstruction with the parietal peritoneum. The long results in 90 patients. HPB, 21(Suppl. 3), S992–S993. https://doi.org/10.1016/j.hpb.2019.10.069. Retrieved November 2025.
17. TUM Klinikum Rechts der Isar, Klinik und Poliklinik für Chirurgie. Operationen an der Bauchspeicheldrüse. Retrieved November 2025.
18. Höhn, P., Runde, F., Luu, A. M., Fahlbusch, T., Fein, D., Klinger, C., Uhl, W., Belyaev, O., members of StuDoQ|Pancreas registry of the German Society for General and Visceral Surgery (DGAV), Keck, T., Werner, J., Nüssler, N., Bartsch, D. K., Germer, C.-T., Friess, H., Mönch, C., Oldhafer, K.-J., & Kalff, J. C. (2023, March 7). Applicability of the surgical risk calculator by the American College of Surgeons in the setting of German patients undergoing complete pancreatectomy: Multicentre study using data from the StuDoQ|Pancreas registry. BJS Open, 7(2), zrac164. https://doi.org/10.1093/bjsopen/zrac164. Retrieved November 2025.
19. Malleo, G., Marchegiani, G., Salvia, R., Butturini, G., Pederzoli, P., & Bassi, C. (2011, March 23). Pancreaticoduodenectomy for pancreatic cancer: The Verona experience. Surgery Today, 41(4), 463–470. https://doi.org/10.1007/s00595-010-4419-5. Retrieved November 2025.
20. Andrianello, S., Marchegiani, G., Bannone, E., Masini, G., Malleo, G., Montemezzi, G. L., Polati, E., Bassi, C., & Salvia, R. (2018, July 31). Clinical implications of intraoperative fluid therapy in pancreatic surgery. Journal of Gastrointestinal Surgery, 22(12), 2072–2079. https://doi.org/10.1007/s11605-018-3887-6. Retrieved November 2025.
21. Bassi, C., Marchegiani, G., Giuliani, T., Di Gioia, A., Andrianello, S., Zingaretti, C. C., Brentegani, G., De Pastena, M., Fontana, M., Pea, A., Paiella, S., Malleo, G., Tuveri, M., Landoni, L., Esposito, A., Casetti, L., Butturini, G., Falconi, M., & Salvia, R. (2022). Pancreatoduodenectomy at the Verona Pancreas Institute: The evolution of indications, surgical techniques and outcomes: A retrospective analysis of 3000 consecutive cases. Annals of Surgery, 276(6), 1029–1038. https://doi.org/10.1097/SLA.0000000000004753. Retrieved November 2025.
22. Azienda Ospedaliera Universitaria Integrata Verona. (2019, December 12). Antibiotic stewardship program in pancreatic surgery: A multicenter time series analysis (BIOSTEPS). ClinConnect, trial registry entry NCT04199494. Retrieved November 2025.
23. Ambrosetti, M. C., Ambrosetti, A., Bariani, M., Malleo, G., Mansueto, G., & Zamboni, G. A. (2024, August 2). Quantitative edge analysis can differentiate pancreatic carcinoma from normal pancreatic parenchyma. Diagnostics, 14(15), 1681. https://doi.org/10.3390/diagnostics14151681. Retrieved November 2025.
24. European Digestive Surgery (EDS). (2023). Prof. Roberto Salvia. Faculty profile, 15th European Digestive Surgery (EDS 2023). Retrieved October 2025.
25. UZ Leuven. (2019, June 28). Minimally invasive keyhole operation is the future of complex pancreatic surgery. News article. Retrieved November 2025.
26. Topal, H., Aerts, R., Laenen, A., Collignon, A., Jaekers, J., Geers, J., & Topal, B. (2022, December 22). Survival after minimally invasive vs open surgery for pancreatic adenocarcinoma. JAMA Network Open, 5(12), e2248147. https://doi.org/10.1001/jamanetworkopen.2022.48147. Retrieved November 2025.
27. KU Leuven University Fund. Pancreatic Cancer Fund. Brochure, KU Leuven / University Hospitals Leuven. Retrieved November 2025.
28. Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV). Zertifizierte Zentren. Overview of certified centers. Retrieved November 2025.
29. OncoMap / OnkoZert. Centers – pancreas. Search interface for certified pancreatic cancer centers. Retrieved November 2025.
30. Chirurgische Klinik, St. Josef-Hospital Bochum. (2012, November 18). 3-Jahresbericht 2004–2006 – Chirurgische Klinik St. Josef-Hospital Bochum. Yumpu e-paper. Retrieved November 2025.
31. Chirurgische Klinik, St. Josef-Hospital Bochum. 6-Jahresbericht. Internal report, Chirurgische Klinik St. Josef-Hospital Bochum. Retrieved November 2025.
32. Katholisches Klinikum Bochum. (2017, July 4). Pankreas-Zentrum im St. Josef-Hospital Bochum gehört zu den besten in Deutschland. Retrieved November 2025.
33. Kimmich, J. (2012). Lebensqualität nach Pankreaschirurgie. Dissertation, Ruhr-Universität Bochum, Medizinische Fakultät. Retrieved November 2025.
34. Slobodkin, I. (2022). Indikationsspektrum und Ergebnisse der chirurgischen Therapie serös-zystischer Neoplasien des Pankreas. Dissertation, Ruhr-Universität Bochum, Medizinische Fakultät. Retrieved November 2025.
35. Universitätsklinikum der Ruhr-Universität Bochum (UK RUB). (2020, March 12). Pankreaszentrum. Retrieved November 2025.
36. HPB Center Rotterdam / Erasmus MC. (2025). Pancreas center Rotterdam – general information. Retrieved November 2025.
37. HPB Center Rotterdam / Erasmus MC. (2025). Pancreas treatments – pancreatic surgery. Retrieved November 2025.
38. Dutch Pancreatic Cancer Group. (2019, September 6). The (cost)effectiveness of neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine based chemoradiotherapy and adjuvant gemcitabine for (borderline) resectable pancreatic cancer (PREOPANC-2 study). Trial protocol version 5. Retrieved November 2025.
39. Versteijne, E., van Dam, J. L., Suker, M, Janssen, Q. P., Besselink, M. G., van Eijck, C. H. J., et al. (2022, April 10). Neoadjuvant chemoradiotherapy versus upfront surgery for resectable and borderline resectable pancreatic cancer: Long-term results of the Dutch randomized PREOPANC trial. Journal of Clinical Oncology, 40(11), 1220–1230. https://doi.org/10.1200/JCO.21.02233. Retrieved November 2025.
40. Dekker, E. N., Theijse, R. T., van Dam, J. L., Janssen, Q. P., Stoop, T. F., Bonsing, B. A., et al. (2025, August 12). Surgical complications in patients with (borderline) resectable pancreatic cancer after neoadjuvant therapy in the PREOPANC-2 randomized controlled trial. Annals of Surgery. Advance online publication. https://doi.org/10.1097/SLA.0000000000006910. Retrieved November 2025.
41. HPB Center Rotterdam / Erasmus MC. (2025). Surgeons – HPB Center Rotterdam. Retrieved November 2025.
42. Clavien, P. A., Barkun, J., de Oliveira, M. L., Vauthey, J.-N., Dindo, D., Schulick, R. D., et al. (2009, August). The Clavien-Dindo classification of surgical complications: Five-year experience. Annals of Surgery, 250(2), 187–196. https://doi.org/10.1097/SLA.0b013e3181b13ca2. Retrieved November 2025.
43. Slankamenac, K. (2014). Complications in abdominal surgery: Assessment, prediction and prevention. Doctoral thesis, University of Amsterdam. Retrieved November 2025.
44. Latenstein, A. E. J., Mackay, T. M., Borgstein, A. B.-J., van Rijssen, L. B., van Santvoort, H. C., & Besselink, M. G. (2021). Effect of centralization and regionalization of pancreatic surgery on resection rates and survival. British Journal of Surgery, 108(7), 826–833. Retrieved November 2025.
45. DeOliveira, M. L., Winter, J. M., Schafer, M., Cunningham, S. C., Cameron, J. L., Yeo, C. J., & Clavien, P.-A. (2006). Assessment of complications after pancreatic surgery: A novel grading system applied to 633 patients undergoing pancreaticoduodenectomy. Annals of Surgery, 244(6), 931–937. https://doi.org/10.1097/01.sla.0000246856.03918.9a. Retrieved November 2025.
46. Karolinska University Hospital. Pancreatic cancer. Retrieved November 2025.
47. Swartling, O., Evans, M., Larsson, P., Gilg, S., Holmberg, M., Klevebro, F., Löhr, M., Sparrelid, E., & Ghorbani, P. (2023, March). Risk factors for acute kidney injury after pancreatoduodenectomy, and association with postoperative complications and death. Pancreatology, 23(2), 227–233. https://doi.org/10.1016/j.pan.2023.01.003. Retrieved November 2025.
48. Larsson, P., Feldt, K., Holmberg, M., Swartling, O., Sparrelid, E., Klevebro, F., & Ghorbani, P. (2022, November). Preoperative heart disease and risk for postoperative complications after pancreatoduodenectomy. HPB, 24(11), 1854–1860. https://doi.org/10.1016/j.hpb.2022.07.002. Retrieved November 2025.
49. Ghorbani, P., Dankha, R., Brisson, R., D’Souza, M. A., Löhr, J.-M., Sparrelid, E., & Vujasinovic, M. (2022, April 9). Surgical outcomes and trends for chronic pancreatitis: An observational cohort study from a high-volume centre. Journal of Clinical Medicine, 11(8), 2105. https://doi.org/10.3390/jcm11082105. Retrieved November 2025.
50. Stoop, T. F., Ateeb, Z., Ghorbani, P., Scholten, L., Arnelo, U., Besselink, M. G. H., & Del Chiaro, M. (2021, March). Surgical outcomes after total pancreatectomy: A high-volume center experience. Annals of Surgical Oncology, 28(3), 1543–1551. https://doi.org/10.1245/s10434-020-08957-x. Retrieved November 2025.
51. International Hepato-Pancreato-Biliary Association (IHPBA). Karolinska University Hospital – Karolinska International HPB Surgery Fellowship. HPB Fellowship Registry. Retrieved November 2025.
52. Barnaclinic+. Hepatobilioancreatic surgery and transplantation. Retrieved November 2025.
53. Ausania, F., Gonzalez-Abós, C., Martinez-Perez, A., Arrocha, C., Pineda-Garcés, C., Landi, F., Fillat, C., & Garcia-Valdecasas, J. C. (2023, January). Postoperative day one systemic inflammatory response syndrome is a powerful early biomarker of clinically relevant pancreatic fistula. HPB, 25(1), 73–80. https://doi.org/10.1016/j.hpb.2022.08.016. Retrieved November 2025.
54. van Bodegraven, E. A., van Ramshorst, T. M. E., Bratlie, S. O., Kokkola, A., Sparrelid, E., Björnsson, B., Kleive, D., Burgdorf, S. K., Dokmak, S., Groot Koerkamp, B., Cabús, S. S., Molenaar, I. Q., Boggi, U., Busch, O. R., Petric, M., Roeyen, G., Hackert, T., Lips, D. J., D’Hondt, M., … Besselink, M. G., for the European Consortium on Minimally Invasive Pancreatic Surgery (E-MIPS). (2024, June 1). Minimally invasive robot-assisted and laparoscopic distal pancreatectomy in a pan-European registry: A retrospective cohort study. International Journal of Surgery, 110(6), 3554–3561. https://doi.org/10.1097/JS9.0000000000001315. Retrieved November 2025.
55. Ausania, F., Landi, F., Martinie, J. B., Vrochides, D., Walsh, M., Hossain, S. M., White, S., Prabakaran, V., Melstrom, L. G., Fong, Y., Butturini, G., Bignotto, L., Valle, V., Bing, Y., Xiu, D., Di Franco, G., Sanchez-Bueno, F., de’Angelis, N., Laurent, A., Giuliani, G., … Giulianotti, P. C. (2023, September 15). Robotic versus laparoscopic distal pancreatectomy in obese patients. Surgical Endoscopy, 37, 8384–8393. https://doi.org/10.1007/s00464-023-10361-x. Retrieved November 2025.
56. Malgras, B., Duron, S., Gaujoux, S., Dokmak, S., Aussilhou, B., Rebours, V., Palazzo, M., Belghiti, J., & Sauvanet, A. (2016, April). Early biliary complications following pancreaticoduodenectomy: Prevalence and risk factors. HPB, 18(4), 367–374. https://doi.org/10.1016/j.hpb.2015.10.012. Retrieved November 2025.
57. Karam, E., Rondé-Roupie, C., Aussilhou, B., Hentic, O., Rebours, V., Lesurtel, M., Sauvanet, A., & Dokmak, S. (2025, February). Laparoscopic pancreatoduodenectomy is safe for the treatment of pancreatic ductal adenocarcinoma treated by chemoradiotherapy compared with open pancreatoduodenectomy: A matched case-control study. Surgery, 178, 108892. https://doi.org/10.1016/j.surg.2024.09.041. Retrieved November 2025.
58. Cabrit, N., Labiad, C., Aussilhou, B., Sartoris, R., Sauvanet, A., & Dokmak, S. (2022, March 24). Laparoscopic pancreatoduodenectomy with resection of the inferior vena cava and reconstruction with a peritoneal patch. Annals of Surgical Oncology, 29, 4358. https://doi.org/10.1245/s10434-022-11550-z. Retrieved November 2025.
59. IRPAC – Hôpital Beaujon. (2025). Beaujon Hospital – Institute for Research in Pancreatology and Digestive Oncology. Institut de Recherche en Pancréatologie et Cancérologie Digestive. Retrieved November 2025.